What are the typical clinical presentations of Kikuchi-Fujimoto disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Presentation of Kikuchi-Fujimoto Disease

Kikuchi-Fujimoto disease typically presents as tender, unilateral cervical lymphadenopathy in the posterior cervical triangle accompanied by fever, predominantly affecting young women of Asian descent. 1, 2

Primary Clinical Features

Lymphadenopathy Characteristics

  • Cervical lymph nodes are usually unilateral, tender, 1.5-4 cm in diameter, and located in the posterior cervical triangle (in contrast to Kawasaki disease which affects the anterior cervical triangle). 1
  • Multiple enlarged nodes are typically present rather than a single node, which helps distinguish this from bacterial lymphadenitis. 1
  • Generalized lymphadenopathy is rare but can occur. 3
  • Ultrasound shows a hypoechoic aspect with an external, thick and irregular hyperechoic ring. 3

Fever Pattern

  • Low-grade fever is common and accompanies the lymphadenopathy. 2, 4
  • Night sweats frequently occur alongside the fever. 2, 4

Associated Symptoms

Common Accompanying Features

  • Headaches are frequently reported. 2
  • Skin rash may be present. 2, 5
  • Mild hepatosplenomegaly can occur. 1
  • Weight loss, nausea, vomiting, and sore throat are less frequent but recognized symptoms. 4, 3

Less Common Manifestations

  • Arthralgia and arthritis may develop. 5, 3
  • Fatigue and weakness are reported. 5, 3
  • Extranodal involvement (skin, eye, bone marrow) is rare. 3

Laboratory Findings

  • Leukopenia or neutropenia with relative lymphocytosis is characteristic. 3
  • Pancytopenia can occur in some cases. 5
  • Elevated inflammatory markers (ESR, CRP) are typically present. 6

Demographic Pattern

  • Predominantly affects young women, especially those of Oriental-Asian origin. 2
  • The disease has worldwide distribution but higher prevalence in Japanese and other Asian populations. 4

Clinical Course

  • Self-limited disorder with spontaneous resolution within 1-4 months. 1, 4
  • Disease typically develops over 1-3 weeks with an acute or subacute course. 3
  • Recurrence is rare (3-4% of cases). 1

Critical Diagnostic Pitfalls

Distinguishing from Kawasaki Disease

  • Kikuchi-Fujimoto affects posterior cervical nodes while Kawasaki disease affects anterior cervical nodes. 1
  • Kawasaki disease requires ≥5 days of fever plus ≥4 principal features (bilateral nonexudative conjunctivitis, oral changes, polymorphous rash, extremity changes, cervical lymphadenopathy ≥1.5 cm). 6
  • In Kawasaki disease, multiple nodes are present with retropharyngeal edema or phlegmon on imaging. 6

Distinguishing from Bacterial Lymphadenitis

  • Bacterial infection typically presents with a single node with hypoechoic core on ultrasound, warmth, erythema of overlying skin, and localized tenderness. 6
  • Kikuchi-Fujimoto shows multiple enlarged nodes without these suppurative features. 1

Other Important Differentials

  • Must distinguish from systemic lupus erythematosus, malignant lymphoma, tuberculosis, and other infectious lymphadenitis. 2, 4
  • The absence of neutrophils, plasma cells, and hematoxylin bodies on histology argues against SLE. 3
  • Absence of auto-antibodies and anti-nuclear antibodies helps rule out autoimmune disorders. 3

Definitive Diagnosis

  • Diagnosis requires excisional lymph node biopsy showing paracortical foci of coagulative necrosis with karyorrhectic debris, surrounded by CD68+ histiocytes and CD8+ lymphocytes. 4, 3
  • Three histological patterns are recognized: proliferative, necrotizing, and xanthomatous. 2

Associated Conditions

  • Associations noted with viral infections (EBV, HSV, VZV). 2
  • Associations with autoimmune disorders including SLE, Sjogren's syndrome, rheumatoid arthritis, and Hashimoto's thyroiditis. 2, 5
  • Cases reported following mRNA COVID-19 vaccination. 7
  • Patients should be followed for several years to monitor for possible development of systemic lupus erythematosus. 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.